Vaccine Research Center

And so maybe just a quick sort of side note here is that the other part of our work recently has been to conduct clinical trials of anti-malaria monoclonal antibodies in Africa.

And this is work with a close friend and collaborator, Bob Seder at the Vaccine Research Center at the NIH, who isolated some very potent monoclonal antibodies that target a protein on this first stage.

of the infection.

And we find in clinical trials that a single dose of antibodies against sporozoites can protect for up to six months against infection, like completely blocking the infection at the first stage.

Uh, the agency authorized COVID vaccines for infants and toddlers, including those who had COVID, and second, the fact that just months before, they bypassed the external experts to authorize booster shots for young children.

The NIH's Vaccine Research Center has had many of the senior scientists leave, including, uh, a couple of the director and deputy director and chief medical officer, all left.

No, no leadership anymore.

They've ex- CDC's had a similar problem.

This paragraph was discussing who is Barney Graham, and it said that he is the professor of microbiology at Morehouse School of Medicine in Atlanta, home of the CDC.

He is formerly the deputy director of the Vaccine Research Center, part of Fauci's NIAID.

Graham is holder of 38 patents related to immunization.

In particular, US 10960070 B2, prefusion coronavirus spike proteins and their use, granted in 2017.